Background: Increased skin Staphylococcus aureus colonization is frequently found in atopic patients. The reduction of local overinfection decreases skin inflammation and improves the flares. Objective: To evaluate the effectiveness of the antimicrobial activity of a silk fabric (MICROAIR DermaSilk®) coated with alkoxysilane quaternary ammonium with durable antimicrobial properties (AEGIS AEM 5572/5) in children affected by atopic dermatitis (AD). Methods: Sixteen children, 12 affected by AD with symmetric eczematous lesions on the antecubital areas and 4 without any cutaneous disease, used, for 7 days, tubular arm covers made of this special silk fabric but only one of each pair was coated with AEGIS AEM 5572/5. Microbiological examinations were done with standard cultural swabs and by means of quantification of bacterial agents using agar plates at baseline, after 1 h and after 7 days. Results: After 7 days a significant improvement in the mean value of the ‘local SCORAD’ index was observed in both the covered areas compared to the values obtained at baseline. The reduction in the mean number of colony forming units per square centimetre was similar in both areas. Conclusions: Although this special silk fabric seems to be able to improve skin lesions in AD, we were unable to demonstrate that such silk fabrics coated with AEGIS AEM 5572/5 have an antibacterial activity in vivo, as shown in vitro.

Keywords:
Atopic dermatitis, Silk textile, Antibacterial properties, Quaternary ammonium, Staphylococcus aureus
1.
Williams JR, Burr ML, Williams HC: Factor influencing atopic dermatitis – a questionnaire survey of schoolchildren’s perceptions. Br J Dermatol 2004;150:1154–1161.
2.
Hermanns JF, Goffin V, Arrese JE, Rodriguez C, Pierard GE: Beneficial effects of softened fabrics on atopic skin. Dermatology 2001;202:167–170.
3.
Leung DYM, Bieber T: Atopic dermatitis. Lancet 2003;361:151–160.
4.
Brockow K, Grabenhorst P, Abeck D, et al: Effect of gentian violet, corticosteroid and tar preparations in Staphylococcus aureus-colonized atopic eczema. Dermatology 1999;199:231–236.
5.
Remitz A, Kyllonen H, Granlung H, Reitamo S: Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. J Allergy Clin Immunol 2001;107:196–197.
6.
Pournaras CC, Lubbe J, Saurat JH: Staphylococcal colonization in atopic dermatitis treatment with topical tacrolimus (Fk506). J Invest Dermatol 2001;11:480–481.
7.
Gauger A, Mempel M, Schekatz A, Schafer T, Ring J, Abeck D: Silver-coated textiles reduce Staphylococcus aureus colonization in patients with atopic eczema. Dermatology 2003;207:15–21.
8.
Ricci G, Patrizi A, Bendandi B, Menna G, Varotti E, Masi M: Clinical effectiveness of a silk fabric in the treatment of atopic dermatitis. Br J Dermatol 2004;150:127–131.
9.
Gettings RL, Triplett BL: A new durable antimicrobial finish for textiles. AATCC Book of Papers 1978, pp 259–261.
10.
Hanifin JM, Rajka G: Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980;92:44–47.
11.
Ricci G, Patrizi A, Neri I, Bendandi B, Masi M: Frequency and clinical role of Staphylococcus aureus over-infection in atopic dermatitis of children. Pediatr Dermatol 2003;20:389–392.
12.
Patel GK, Wyatt H, Kubiak EM, Clark SM, Mills CM: Staphylococcus aureus colonization of children with atopic eczema and their parents. Acta Derm Venereol 2001;81:366–367.
13.
Arima Y, Nakai Y, Hayakawa R, Nishino T: Antibacterial effect of beta-thujaplicin on staplylococci isolated from atopic dermatitis: relationship between changes in the number of viable bacterial cells and clinical improvement in an eczematous lesion of atopic dermatitis. J Antimicrob Chemother 2003;51:113–122.
14.
Senti G, Steinmann LS, Fischer B, Kurmann R, Storni P, Johansen P, Schmid-Grendelmeier P, Wüthrich B, Kündig TM: Anitmicrobial silk clothing in the treatment of atopic dermatitis proves comparable to topical corticosteroid treatment. Dermatology 2006;213:228–233.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.